{
    "organizations": [],
    "uuid": "0733a9f7ea8b226245d4bf21d5f7cd8bf2993da3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-astellas-acquires-universal-cells/brief-astellas-acquires-universal-cells-inc-idUSASB0C5KW",
    "ord_in_thread": 0,
    "title": "BRIEF-Astellas acquires Universal Cells Inc",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Astellas Pharma Inc:\n* ASTELLAS ACQUIRES UNIVERSAL CELLS, INC. * ASTELLAS WILL PAY UP TO $102.5 MILLION OF UPFRONT AND MILESTONES TO ACQUIRE 100 PERCENT OWNERSHIP OF UNIVERSAL CELLS\n* ‍IMPACT OF TRANSACTION ON ASTELLAS’ FINANCIAL RESULTS FOR FISCAL YEAR ENDING MARCH 31, 2018 WILL BE IMMATERIAL​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T03:02:00.000+02:00",
    "crawled": "2018-02-14T03:22:27.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "astellas",
        "pharma",
        "inc",
        "astellas",
        "acquires",
        "universal",
        "cell",
        "astellas",
        "pay",
        "million",
        "upfront",
        "milestone",
        "acquire",
        "percent",
        "ownership",
        "universal",
        "cell",
        "transaction",
        "astellas",
        "financial",
        "result",
        "fiscal",
        "year",
        "ending",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}